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Current debate focuses on the relevance of linkage disequilibrium (LD), ethnicity and underlying
haplotype structure to the search for genes involved in complex disorders. The recently described
association between single nucleotide polymorphisms (SNPs) of the CARD15 (NOD2) gene and Crohn’s
disease (CD) in populations of north-European descent provides a test case that we have subjected to
detailed SNP haplotype based analyses. We examined 23 SNPs spanning 290 kb, including CARD15, in
large North-European and Korean samples of patients with Crohn’s disease and normal controls. In
Europeans we confirmed that the three disease-associated SNPs occur independently but share a
common background haplotype. This suggests a common origin and the possibility of an undiscovered
more strongly predisposing mutation. Korean CD patients present a phenotype identical to the European
patients and have not previously been screened for CARD15. The three disease-associated SNPs were
absent and there was no evidence of association between CARD15 and CD. Consequently, the disease-
associated mutations in the Europeans, which are rare, have arisen recently (after the Asian – European
split). Our results highlight important issues relevant to mapping the genes that predispose to complex
disorders. First, although ethnically divergent populations may present identical phenotypes they do not
necessarily share the same set of predisposing genes. Second, although single-locus tests of association
showed consistent association with markers throughout the gene, pair-wise LD between markers (r2 and
D’) yielded very little information about actual disease-association. Third, a population comparative
approach allowed refining of the marker set through the examination of shared polymorphisms and
common LD-groups. This approach, in conjunction with the examination of the mutational steps in a
haplotype network, allows unambiguous identification of the potentially causative mutations.
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Introduction
Considerable attention is currently being focused on the
genotyping of single-nucleotide polymorphisms (SNPs),
and on their utility for linkage disequilibrium (LD)
mapping studies that hope to identify susceptibility genes
for complex diseases. In the context of LD mapping, it
would be important to identify regions of conserved LDReceived 19 April 2002; revised 22 August 2002; accepted 26 August 2002
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or, alternatively, of high recombination and gene conver-
sion throughout the human genome. One goal here is to
detect the common haplotypes such that the number of
SNPs that need to be genotyped for a gene mapping study
can be reduced.1,2,3 – 5 However, not only do recombination
rates vary greatly across the genome6 but differences in
population history and structure cause the extent of LD
and mutational load at different genes to be population
specific.1,2,4,7 Furthermore, in the case of complex diseases –
where many loci may confer susceptibility – ethnically
divergent populations may exhibit the same phenotype
but this phenotype may not necessarily be caused by the
same set of susceptibility loci. This assumption has been
largely hypothetical; the recently described association of
Crohn’s disease with CARD15 provides an ideal test case.
Crohn’s disease (CD; MIM 2666600) and ulcerative colitis
(UC; MIM 191390) represent the two major forms of
inflammatory bowel disease (IBD; MIM 601458). These
diseases are characterized by chronic relapsing inflamma-
tion of the gastrointestinal tract.8,9 The prevalence of IBD
in some western countries is as high as 0.5%.10,11 Consis-
tent evidence for familial clustering,12 an increased
concordance of the IBD phenotype in monozygotic
twins13,14 and consistently positive results from genetic
linkage studies have repeatedly confirmed the involvement
of complex genetic factors in the etiology of these condi-
tions.
Genome-wide linkage analyses have detected several
susceptibility regions on different chromosomes and the
linkage region on chromosome 16, IBD1.15 This has been
replicated in several independent Caucasian popula-
tions.16 – 25 Recently, mutations in the leucine rich region
(LRR) of the CARD15 (NOD2) (MIM 605956) gene on chro-
mosome 16q12 have been discovered. These mutations are
strongly associated with CD in populations of European
descent.26 – 28
CARD15 is a member of the APAF-1/CED-4 family of
genes. Genes from this family show some structural simila-
rities to plant NOD resistance genes, and have been
implicated in pro-inflammatory cytokine induction and
apoptosis pathways involving TNFa and NFkB, with
CARD15 exhibiting monocyte-specific expression.28,29 Pre-
liminary functional evidence has suggested that the LRR
regions of CARD15 may play a role in the response to
bacterial lipopolysaccharides by altering the activation of
NFkB.28,30 However, the exact functional and molecular
role of CARD15 in the immune response remains unclear.31
Three mutations in the LRR have been implicated in CD.
Two of these, C14772T (R702W) in exon 4 and G25386C
(G908R) in exon 8 (labelled SNP8 and SNP12, by Hugot et
al;27 from here on referred to as o8 and o12) cause amino
acid substitutions. The insertion of a C in exon 11,
32629insC (1007insC) (labelled SNP13, here=o13) causes
truncation of the protein. It has been suggested that the
three mutations could alter activation of NFkB through
inefficient CARD15 dimerization or impaired recognition
of microbial components.27,28
Hugot et al.27 indicated that the CARD15 mutations
never occur on the same chromosome and identified three
haplotypes that show markedly distorted transmission in
affected nuclear families. These three haplotypes are identi-
cal except that each carries one of the three mutations.
Although, the three mutations are present on other haplo-
types these are too rare to allow detection of disease-
association.
Three independent causative mutations occurring on the
same haplotype background does not appear parsimonious
and suggests that a further, truly causative or more strongly
predisposing mutation may exist that is in some LD with
the three LRR mutations. Presence of the haplotype carry-
ing this unknown mutation would thus be a prerequisite
for any other variation to be classified as disease-associated.
It was decided, therefore, to perform a detailed study of
the genetic variation in and around the entire CARD15
gene. The aim was twofold. First, to determine whether
CARD15 confers susceptibility to CD in an ethnically and
historically distinct Asian population – susceptibility that
has previously been demonstrated for several populations
of predominantly European descent. To this end, data from
a South Korean cohort are presented and patterns of LD and
underlying haplotype structure are compared between
Europeans and Asians. Second, the possibility of a common
mutation in LD with the previously described, putatively
causative LRR mutations is explored.
Subjects and methods
Subjects
British families (75 CD-affected pedigrees containing 162
CD-affected individuals and 72 affected sib-pairs (ASPs))
and German families (144 CD-pedigrees; 265 CD-indivi-
duals, 124 ASPs) were recruited by an international group
of IBD investigators at the Charite´ University Hospital
(Berlin, Germany), the Department of General Internal
Medicine at Christian-Albrechts-University (Kiel, Germany),
St Mark’s, Guy’s and King’s College Hospitals (London, UK)
and other German centres. These cohorts have been
described in previous studies.16,26 Additionally, German
trios (307 patients with sporadic CD and two unaffected
parents) were recruited. Normal controls (370 individuals)
of German origin were obtained through the Department
of Transfusion Medicine at the Kiel University Hospital.
South Korean sporadic CD cases (126 individuals) and unre-
lated healthy controls (116 individuals) were recruited at
the Department of Internal Medicine, University of Ulsan
College of Medicine, Asan Medical Center, Seoul and the
Department of Internal Medicine, Yonsei University College
of Medicine, Seoul.
The diagnosis of CD was confirmed by clinical, radio-
logical and endoscopic (type of lesions, distribution)
analyses.32,33 Additionally, histological findings had to be
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confirmative or complementary with this diagnosis. The
diagnosis in the Korean patients was additionally controlled
by an observational visit from the Kiel group. EDTA blood
was obtained from all study participants. Informed, written
consent was obtained from all study participants and
recruitment protocols were approved by ethics committees
at participating centres before commencing the cohort
assemblies.
Methods
The CARD15 gene was screened for SNPs by genomic and
cDNA resequencing in 47 IBD affected German patients
(24 CD, 23 UC). Searching for new SNPs only in affected
individuals maximizes the likelihood of finding disease
associated mutations (however, we note that putative
protective polymorphisms may be overlooked, on occasion,
using this strategy). Mutation detection focused on the
exons, exon – intron boundaries and on 1 kb regions flank-
ing the gene at approximately 50, 100, 150 and 200 kb up
and downstream of the ATG. Primers for PCR amplification
were designed on the basis of GenBank sequences
NT_027173 and XM_012541). In total, 23 polymorphisms
are reported. These include those previously reported as
associated with CD susceptibility (accession numbers to
dbSNP: ss2978533, ss2978538, ss2978540-43, ss2992220-
24, ss2992238-39, ss2992242, and ss4383587-95).
The SNPs were genotyped using Allelic Discrimination by
Taqman Technology with an ABI 7700 Sequence Detector
(Applera, Foster City, CA, USA) using the primers and
probes as outlined in Table 1.
The same regions were screened for mutations in 47
Korean CD patients by genomic resequencing with geno-
typing and confirmation of sequencing results using the
Taqman assays established in the European samples.
The data were checked and managed by means of an
integrated database system.34
Statistical analyses
Each marker was tested for Hardy – Weinberg equilibrium
in the control populations using a w2 test. Genetic
analyses were then performed at several levels. To confirm
the association with CD, each marker was first subjected
to single-locus tests for linkage as follows. The UK
families, German families and German trios were exam-
ined for distorted transmission using the TRANSMIT
program35,36 with significance levels verified using 1000
bootstrap replicates for each test. A case – control analysis
was performed against unrelated controls on the Korean
dataset, and also on the European data after randomly
extracting a single affected offspring from each family or
trio. In all analyses, the UK and German data were pooled
into a single European cohort. The validity of such pool-
ing was verified by comparing the allele frequencies at
each marker in the random cases using w2 statistics or
Fisher’s exact test, as appropriate (data not shown). Geno-
type-based odds ratios (OR) were calculated and
association tested similarly.
Pair-wise LD between each marker pair was calculated as
D=pij – pipj, where pij is the frequency of haplotype carrying
allele i at the first locus and allele j at the second locus, and
pi and pj are the frequencies of alleles i and j. This was trans-
formed into the two standardized LD coefficients, r2 and D’.
Here, r is the allelic correlation coefficient given by D/
(pipj[1-pi][1-pj])
1/2.37 D’ was computed as Dij/Dij,max, where
Dij,max is the maximum LD possible for two markers with
allele frequencies pi and pj, calculated as min (pipj, [1-pi][1-
pj]) if Dij 50 or min ([1-pi]pj, pi[1-pj]) if Dij 40.
38
Haplotypes frequencies were estimated from phase-
unknown and phase-known genotypic data using the
Expectation Maximisation (EM) algorithm.39 All individuals
with incomplete genotypes were removed from the analy-
sis. The haplotype frequency estimates from the EM
algorithm were cross-checked against the European family
and trio data, using the program GENEHUNTER 2.
The EM algorithm uses maximum likelihood approaches
to estimate haplotype frequencies from partially phase-
unknown genotypic data. Large numbers of markers gener-
ate prohibitively intensive searches and therefore subsets of
informative markers had to be selected. This choice was
based both on the comparison of the two populations
and the patterns of LD observed between the markers (see
Results).
The null-hypothesis that there is no difference in overall
estimated haplotype frequencies between cases and controls
could be tested using a likelihood ratio test. However, esti-
mated haplotype frequencies cannot be treated as observed
data and therefore no valid statistical test exists for evaluat-
ing the possible contribution of individual haplotypes to any
deviation from this null-hypothesis. Consequently, a robust
permutation test for haplotype association was performed.
Pseudo-w2 statistics were calculated both for the overall
haplotype tables (global test) and the individual haplotypes
in the tables. The significance of these statistics was evalu-
ated by shuffling-together and repartitioning the case and
control individuals, re-estimating the haplotype frequencies
and then re-calculating the pseudo-w2 statistics 10 000 times.
Evaluating the contribution of individual haplotypes is only
strictly relevant if the null-hypothesis of no difference in
overall estimated haplotype frequencies between cases and
controls (the global test) is rejected; this evaluation does
not represent a new statistical hypothesis and therefore
correction for multiple-testing is not necessary.
The NETWORK 3.0 program was used to infer the likely
genealogical history between the most frequent haplotypes
using the Median – Joining (MJ) algorithm.40 In an MJ
network, circles represent distinct haplotypes and are scaled
to reflect the frequency of these haplotypes. The branches
connect the haplotypes and indicate the mutational steps
between the haplotypes. The MJ network was generated
for the set of European case and control haplotypes.
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Results
CARD15 diversity at the nucleotide level
The CARD15 gene consists of 12 exons spanning 35.9 kb of
genomic sequence and encoding an mRNA transcript of
4486 bp. All exons and exon – intron boundaries of the
CARD15 gene, plus 1 kb regions flanking either side of
the gene at 50, 100, 150 and 200 kb intervals, were
screened in 47 patients (94 chromosomes) each, from both
the European and Korean CD samples. In the European
patients, a total of 23 SNPs, spanning 290 kb, were
confirmed and genotyped, giving a mean density of one
SNP per 12.6 kb (one SNP per 2.3 kb in the CARD15 coding
region). Only 10 of these SNPs were present in the Korean
samples, and no additional variants were identified in this
population. The absence of variants on sequencing was
further confirmed using the TaqMan assays, previously
established in the European population. Most notably
absent were SNPs R702W, G908R, and 1007insC, which
correspond to the disease-associated SNPs (o8, o12, o13)
as outlined by Hugot et al.27 Indeed, only two of the SNPs
described by Hugot et al.27 were present in the Korean
sample – SNPs 10 and 14 (o7 and o9). The SNPs with their
positions, nomenclature, coding status and frequencies are
summarized in Table 2.
Table 1 TaqMan assay primer and probe sets
SNP Primers Probesa
1 F: CCCCAACCCCTGCTCAA G: TGCCTCTGCTCTGTCTTCTTGTAGGAGCT
R: TCTCTCAACACGTCGCCCA C: TGCCTCTGCTCTGTCTTCTTCTAGGAGCTC
2 F: CCGTTGTCAAACACAATGACG C: CTGCATAATAGACCGAGCCCAGATG
R: TGCAAAGCTCTCGTGAGGG T: ACTGCATAATAGATCGAGCCCAGATGTT
3 F: TGCTTACCACAAACTTAGAGACTTTTCT G: CGATGCGAGCTGAAGCGATCTC
R: CTGGAAGCACGTCAAACTGC A: CGATGCGAGCTGAAGCAATCTCA
4 F: CCCCTTCGAGCTCTTGGTTC G: AGCTCCGGCGACAAGCCG
R: AACTTAGAAAGTGGCAGCCCCCT A: AGCTCCGGCAACAAGCCGAG
5 F: GAGGTGTCCAGGCTCAGGC A: CCCACGTGGGTCACCCCTTGA
R: CCAAGGTGAGGCCCATGTAG G: CCACGTGGGTCGCCCCTTG
6 F: GACCACCCTGCATCTGGCT T: CTGGAGAAGTCCCCTCACT
R: GAGCACATTTCACAACCTGGG G: CTGGAGAAGTCCCGCACT
7 F: CAGCCATGTGGAGAACATGC C: CCGATCTTCACACCGTCCCAGAGG
R: AGCACCCCTTTCCTGAGAACT G: CCGATCTTCACACCGTCGCAGAGG
8 F: GGAGGACATATACACAGAGAATGTCC C: ATGGCTGGACCCCCGCAGAAGAG
R: CATCGTCATTGAGGTGGCC T: ATGGCTGGATCCCCGCAGAAGAGC
9 F: TCGGCGTTCCTCAGGAAGTA C: AGGAAGCGCCATCATGAGCCCG
R: TGAGGTCTCTTGGAGCAGGC T: AGGAAGCGTCATCATGAGCCCGG
10 F: AACGCGGCAAAGAAGCACT A: ACGACACCTTTGGCACGCACCAGA
R: ACGTGTTCTCAGCCCAGCA C: CGACACCTTTGGCCCGCACA
11 F: TTCCTGGCAGGGCTGTTGTC C: CCTGCTCCGGCGCCAGGC
R: AGTGGAAGTGCTTGCGGAGG T: CCTGCTCTGGCGCCAGGCC
12 F: ACTCACTGACACTGTCTGTTGACTCT G: TTTTCAGATTCTGGGGCAACAGAGTGGGT
R: AGCCACCTCAAGCTCTGGTG C: TTCAGATTCTGGCGCAACAGAGTGGGT
13 F: TTGTCCTCTCAGGGTTTTGAT A: CATTTTATCTTAAGGACCAATTC
R: CTTTAAGCCCAGGTGCAGC G: TTTTATCTTAAGGGCCAATTC
14 F: GAATTCTCTTGCAAATATGTCCCTG A-: AATTGAGAATCCCCACAACGTAATTATCTG
R: AAACCCAAACTCATGGATAAAGAAA CT: TTGAGAATCCCCACAACGTACTTTATCTG
15 F: GTCCAATAACTGCATCACCTACCTAG -: CCCTCCTGCAGGCCCTTGAAAT
R: CTTACCAGACTTCCAGGATGGTGT C: CCTCCTGCAGGCCCCTTGAAA
16 F: GCCCATGGATGTGCTTGTTA A: AAAGACCCCTTACCACTGCTCTGATGAAGA
R: CCTGGATGGATGAGTCGAGA C: AAAGACCCCTTCCCACTGCTCTGATG
17 F: GTAAATTGTCAGATGCTGTGCAAA A: AAACTGGTTAATATTTATAGATCACTTT
R: CACGGCCATGTTGTCTATAAGAGTA G: AACTGGTTAATATTTATAGGTCACTTT
18 F: CATCCGAGCCCCAGCTT C: CAGCGAAATGGGGATCATTAAGACCTACATTATAAG
R: CCAGGCCCTGAGTTAGACGA T: CAGCGAAATGGGGATCATTAAGACTTACATTATAAGT
19 F: TTACAACAAAAGAAACTGAGGACCTG G: AAACAATTCAGTTGGCTTATTCAATTGTGATCCTT
R: CCATGGAGATATATTTTGTCTCTAATTCTATAAA T: AAACAATTCAGTTTGCTTATTCAATTGTGATCCTTG
20 F: CATCAAGTAAAGCAAAGTATGTCACACT A: TAAAATTGAAATAAAGCTATCATTTGA
R: GGGCATGCTTTCTGCTTTAGTT C: AATTGAAATAAAGCTCTCATTTG
21 F: GCGATGCTGGCTGAGTTTG C: TTTATACCAACTGGACAGAACACAGTCTTCCTCTTT
R: AGCTGAGCCAGGAGGCAAG T: TTTATACCAACTGGACAGAATACAGTCTTCCTCTTTCTT
22 F: GCCACATCCATGCCAAGA C: CTGCATAGGCTGGACCGACCGTG
R: GCCAAAGGTCTCTGCTGCTT T: CTGCATAGGCTGGACTGACCGTGG
23 F: GCACCCATCCCTGGAGCTA C: TGGAGGTGGGCTTAGCTCCACCAA
R: TCCCTCCCTATTCTCAATTCATGT T: TGGAGGTGGGCTTAGCTTCACCAAACT
aSome assays designed on the reverse strand.
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Table 2 also outlines the results of the single-locus tests
of association for each SNP. In the European samples, the
TDT and case – control results are complementary, with
non-significant results obtained for the most distal flanking
markers (SNPs 1, 22, 23) and also for SNP 19, but consis-
tently significant association for all other markers within,
or close to, the gene. In the Koreans, none of the markers
exhibits any significant association to CD as assessed by a
case – control design. Only SNP 2 and SNP 22 suggest
marginal significance, which dissipates on correction for
multiple testing and is not supported by two-marker haplo-
type analysis (data not shown).
LD in CARD15
LD was studied between CD associated SNPs 1007insC,
G908R and R702W (o13, o12, o8 respectively) and the
remaining SNPs. These results (Figure 1) clearly highlight
the problems inherent to LD metrics r2 and D’. According
to r2, SNPs 1007insC, G908R and R702W are not in linkage
disequilibrium with each other, nor with any other
markers. The low r2 values most likely result from the low
frequency of the rare allele of each SNP (see Table 2); r2 is
known to be highly sensitive to skewed allele-frequen-
cies.7,41 The values of D’ are, however, also problematic.
For many combinations, D’ values of 1.0 result and these
again are mainly due to the low frequencies of SNPs
1007insC, G908R and R702W. By definition, the presence
of only three of four possible haplotypes results in D’ being
equal to unity. Measures of marker – marker LD, as
employed here, are therefore not helpful for deciding if rare
disease-associated variants such as SNPs 1007insC, G908R
and P268S (SNP8) are co-segregating with other (perhaps
causative) mutations.
LD was also calculated between other pairs of markers.
Figure 2 shows how D’ and r2 values decrease with distance
between markers in the European samples. A value of
r240.1 has been suggested as a criterion for meaningful
LD7,42 whereas a cut-off of r240.5 is perhaps more useful
for visualizing LD-groups.7 Examining Figure 2 from this
perspective suggests that useful LD in CARD15 declines
sharply with distance and extends maximally to between
50 and 100 kb. Overall, LD in the European sample and
the Korean sample appeared similar (mean pair-wise r2
between markers: European=0.18+0.03, Korean=0.24+
0.09; mean pair-wise D’ between markers: European=
0.68+0.05, Korean=0.65+0.11).
Figure 3 illustrates pair-wise LD between all marker pairs
for the European (lower diagonal) and Korean (upper diag-
onal) control populations. D’ values are explicitly
presented whilst, r2 values 40.5 are indicated in black,
and r2 values between 0.25 and 0.5 are highlighted in grey.
Following the methodology of Nakajima et al,7 r2 values
40.5 were used to identify LD-groups (Figure 3, bottom).
With the exception of SNP2, all SNPs present in the Korean
Table 2 SNPs and association statistics in Europeans and Koreans
SNP Frequency TDT Case – controlc
European Korean
Hugot et al. Controls Controls European European Korean
Designation Varianta Location (2001) (n=740)b (n=232)b (526 families) (n=1008 cases)b (n=252 cases)b
1 G-84336C 0.470 1.000 NS 0.98; NS
2 T-39739C SNP1 0.258 0.418 p=0.0012 1.48; p50.0056* 0.53; p=0.03*
3 G-21889A SNP2 0.191 0.000 p=0.0001 2.11; p50.0001
4 G-16426A SNP3 0.454 0.000 p=0.0004 0.52; p50.0001
5 G-936A SNP4 0.314 0.000 p=0.0001 1.76; p50.0001
6 T2220G Intron 1 0.288 1.000 p=0.0001 1.99; p50.0001
7 C2705G Exon 2 0.407 0.078 p=0.0007 0.53; p50.0001 0.58; NS
8 C13470T (P268S) Exon 4 SNP5 0.299 0.000 p=0.0001 1.75; p50.0001
9 C14045T Exon 4 SNP6 0.301 0.000 p=0.0001 1.80; p50.0001
10 T14429G Exon 4 SNP7 0.402 0.112 p=0.0002 0.52; p50.0001 1.77; NS
11 C14772T (R702W) Exon 4 SNP8 0.047 0.000 p=0.0001 2.68; p50.0001
12 G25386C (G908R) Exon 8 SNP12 0.006 0.000 p=0.0105* 8.17; p50.0001
13 A25727G Intron 8 0.284 0.000 p=0.0001 1.87; p50.0001
14 CT28113A Intron 9 SNP9 0.419 0.181 p=0.0007 0.55; p50.0001 1.25; NS
15 32629insC(1007insC) Exon 11 SNP13 0.050 0.000 p=0.0001 3.50; p50.0001
16 A34974C 3’UTR 0.422 0.200 p=0.0066* 0.50; p50.0001 1.01; NS
17 G35733A 3’UTR 0.408 0.191 p=0.0094* 0.56; p50.0001 1.21; NS
18 G59545A 0.475 0.826 p=0.0161* 1.56; p50.0099* 0.64; NS
19 A59851C 0.023 0.000 NS 0.72; NS
20 T60096G 0.421 0.113 p=0.0006 0.55; p50.0001 1.86; NS
21 A112332G 0.043 0.000 p=0.0250* 1.97; p50.0032*
22 G162674A 0.253 0.208 NS 0.80; NS 1.91; p=0.02*
23 C206363T 0.462 0.314 NS 0.75; NS 1.15; NS
aVariant position counted from the A in the ATG initiator codon. bn=number of chromosomes. cGenotype odds-ratio precedes the P-value.
*=Non-significant (NS) after Bonferroni correction for multiple testing. Dunn-Sˇida´k Pcritical=0.0022; 23 tests (European); Pcritical=0.0051; 10 tests
(Korean).
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controls fell into one LD-group. In the European sample,
two LD-groups were apparent – one coinciding almost
exactly with the Korean markers and one containing the
other markers, except SNPs R702W G908R, 1007insC, 21,
1, 2, 22, 23 (the latter four, which are the most distal,
showed little overall linkage disequilibrium with the other
SNPs).
Haplotype analysis
Haplotypes were constructed using an EM algorithm with
two sets of SNPs; those shared between Europeans and
Koreans (set 1), and those exclusively found in Europeans
(set 2). SNPs 1, 2, 22 and 23 were eliminated from the
haplotype analysis on the grounds of too little LD. Only
haplotypes with estimated frequencies greater than 1% in
Figure 1 Pair-wise LD between 1007insC (A), G908R (B), and R702W (C) and other CARD15 SNPs. Both r2 (dotted line, triangle) and D’
(solid line, diamond) are displayed.
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the combined cases and controls were considered. Haplo-
type frequencies for SNP set 1 were analysed for a
difference between cases and controls in both the Korean
and European samples. The estimated haplotypes and corre-
sponding statistics are given in Table 3. For both
populations, the global permutation test indicated no asso-
ciation with CD. Furthermore, and in agreement with this,
no individual haplotypes indicated significant association
with CD. Given the lack of association in either population
for haplotypes inferred from the shared LD-group (SNP set
1), plus the lack of single point association for these SNPs
in the Korean sample, it seems unlikely that any of these
SNPs are directly involved in the aetiology of CD.
Haplotype frequencies were also estimated for the
European case and control samples using only the markers
unique to Europeans (set 2; Table 4). The global permuta-
tion test was highly significant. Four haplotypes,
designated H1, H2, H5 and H7, were negatively associated
with CD (combined OR=0.295; Wald 95% CI=0.228 –
0.382; ORs are haplotype ORs derived from the estimated
haplotype frequencies). H2, the second most common
haplotype, represents the Korean haplotype and is therefore
probably ancestral. Three haplotypes, H3, H4, and H8, were
positively associated with CD (H3: OR=4.857, Wald 95%
CI=2.923 – 8.075; H4: OR=2.975, Wald 95% CI=1.831 –
4.834; H8: OR=27.493, Wald 95% CI=3.409 – 221.750). H3
carried the mutant form of SNP15 (o13, 1007insC), H4
carried SNP11 (o8, R702W) and H8 carried SNP12 (o12,
G908R). Taken together these three haplotypes account
for 30.2% of the chromosomes in the CD sample and only
7.7% of the chromosomes in the control sample. The over-
all OR was 5.186 (Wald 95% CI=3.635 – 7.400).
Figure 4 shows the MJ network for the 12 most frequent
haplotypes occurring in the European (set 2) combined case
and control sample (92% of the chromosomes). The topol-
ogy was identical if only the controls (or cases) were
analysed. The squared box represents the ancestral haplo-
type shared between the Korean and European
population. The mutational steps (SNPs) between each
node are marked and the nodes are scaled relative to the
count of the haplotype. SNP3 was rejected from the analysis
as uninformative due to homoplasy (recombination). This
resulted in the identity of haplotypes H5 and H7 (indicated
as H5 in Figure 4). Overall, the MJ network placed the
haplotypes into two groups. The putatively ancestral haplo-
type H2, shared between the Korean and European
populations, along with the common H1 dominated one
half of the network. Most other haplotypes, including all
the positively and negatively associated haplotypes fell into
a complex grouping distinct from these common haplo-
types. If the mutational steps across the network are
examined then it is apparent that the only mutations
unique to the positively disease-associated haplotypes H3,
H4 and H8 are SNPs 1007insC, R702W and G908R respec-
tively. All other mutations are shared by other haplotypes
not positively associated with CD (see Table 4). Therefore
it seems unlikely that any of the SNPs examined, other
than SNPs R702W, G908R and 1007insC, is strongly impli-
cated in CD susceptibility.
Discussion
Although the exact nature of the molecular role of CARD15
(NOD2) in mediating the immune response remains
unclear,31 the fact that it is involved in inflammatory disor-
ders seems unequivocal. Not only have mutations in the
LRR of the CARD15 gene been repeatedly reported in asso-
ciation with CD26 – 28 but mutations in the nuclear binding
domain (NBD) have now been implicated in Blau syndrome
(BS; MIM 186580),43 another granulomatous disorder with
histological similarities to sarcoidosis (MIM 181000).
However, the NBD mutations appear to be restricted to
familial BS and have not so far been observed in the general
population.43
The results presented here illustrate a number of impor-
tant points pertinent to the mapping and characterization
Figure 2 Pair-wise LD and distance (kilobases) between 23
SNP markers in Europeans. LD declines sharply with increasing
distance. (A) Absolute values of D’. (B) r2.
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of disease genes, not only for CD but for complex disorders
in general. The single locus tests of association for the
European samples (Table 2) highlight that, given a suffi-
ciently large sample, consistent association between CD
and variation in the CARD15 gene can be detected through-
out the length of the gene and in the surrounding area (in
the case of CARD15 a region of around 100 kb). This result
implies that in a well-designed experiment, one would be
unlikely to overlook the association with CD. On the basis
of association alone, however, it is impossible to ascertain
which, if any, of the SNPs may be causative.
Measuring pair-wise LD between markers may also not be
particularly informative. The values of D’ and r2 between
SNPs R702W, G908R and 1007insC and all other SNPs
yielded very little information about actual disease-associa-
tion. For example, if association had initially been detected
to SNP 3 during an SNP based genome scan, subsequent
assessment of pair-wise LD using r2 values would have failed
to find linkage disequilibrium to SNP R702W, G908R and
1007insC. LD therefore, does not provide a short-cut; full
genotyping of patients is required at each marker. As
previously mentioned, the values of r2 may have been so
low because the predisposing mutations are rare. For similar
reasons, D’ values often attain their maximum value of 1.0.
This happens whenever one or more of the four possible
Figure 3 Pair-wise LD of SNPs in CARD15 as measured by D’ (numbers) and r2 (shading). Top diagonal: Korean. Bottom diagonal:
European. LD-groups defined by markers with r2 values 40.5 are illustrated below.
Table 3 Haplotypes from the shared SNP set 1.
Korean Haplotypesa Frequencyb Significance
Controls CD
7 10 14 16 17 18 20 n=146 n=196
C T CT A G A T 79.37% 73.33% NS
. G A – C A G G 5.41% 10.11% NS
. . . . . G . 4.18% 3.13% NS
G . A – C A G . 4.79% 2.00% NS
. . . C A G . 1.38% 1.94% NS
. G A – . A G G 0.00% 2.14% NS
Global Test=NS
European Haplotypesa Frequencyb Significance
Controls CD
7 10 14 16 17 18 20 n=146 n=196
C T CT A G A T 45.97% 56.50% NS
G G A – C A G G 36.88% 23.54% NS
. . . . . G . 8.01% 10.65% NS
G G A – C . G G 1.60% 1.77% NS
. . A – C A G G 1.75% 1.25% NS
G . . . . . . 1.05% 1.07% NS
. . . . . G G 1.23% 0.74% NS
Global Test=NS
aIdentify with the most frequent haplotype is indicated by a period.
bOnly haplotypes with estimated frequencies 41% in the
combined case and controls are included.
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haplotypes between two markers is absent. One reason that
a marker allele may be rare is because it has arisen recently
– this means that there has been no time for the fourth
haplotype to appear. Hence D’ is not a sensitive measure
of LD to recent and/or rare mutations.7
Allowing for the limitations given above, pair-wise
measures of LD were quite high between all SNPs. Figure
3 illustrates how substantial LD in European CARD15 genes
appears to extend between about 50 and 100 kb. This fits
with the apparent average range of 60 kb ‘typical’ for genes
in populations of northern European descent.1
Use of r2 revealed two LD-groups in the Europeans
(excluding a number of apparently unlinked markers –
notably the rare SNPs R702W, G908R, 1007insC and 19,
and the distantly flanking markers). One LD-group reflected
the set of SNPs and the LD-group observed in the Korean
population, a result that makes intuitive sense. These
markers were generally of moderate to high polymorphism
and no doubt represent relatively ancient and ethnically
shared variation. The ORs of less than 1.0 shown by most
of these markers in the Europeans, in addition to the lack
of single-point association with CD in the Korean popula-
tion and the lack of association in both populations at
the haplotype level, argues strongly against their involve-
ment in CD. This result demonstrates the value of a
population comparative approach to identifying the causa-
tive variations in susceptibility genes for complex disease.
The analysis of the European population using the set of
markers not shared with the Koreans yielded few haplo-
types. The results corroborated those of Hugot et al.27 in
that the three putatively causative mutations did not occur
together on a single haplotype but shared a common back-
ground haplotype. From these results, it is still not feasible
to distinguish between causality of these mutations and of
others on the same background haplotype. However, a
genealogical network approach, placing the haplotypes into
a network, allowed exclusion of all other markers except
SNPs R702W, G908R and 1007insC as predisposing to CD.
Consequently, from our set of 23 SNPs no evidence was
found for a further causative variant that unites SNPs
Table 4 Final European haplotypes (SNP set 2)
European Haplotypesa Frequencyb Significance
Controls CD
3 4 5 6 8 9 11 12 13 15 19 21 n=574 n=564
H2 G G G G C C C G A - A A 23.43% 17.00% P=0.0133
H1 . A . . . . . . . . . . 41.42 28.99 P50.0001
H3 A . A T T T . . G C . . 3.40 14.60 P50.0001
H4 A . A T T T T . G . . . 4.15 11.41 P50.0001
H5 A . A T T T . . G . . . 9.86 4.15 P=0.0004
H6 . . A T T T . . G . . G 2.23 2.39 NS
H7 . . A T T T . . G . . . 3.45 1.24 P=0.0319
H8 . . A T T T . C G . . G 0.16 4.22 P50.0001
H9 . . A T . . . . . . . . 2.10 1.97 NS
H10 . . A T T T . . . . . . 1.92 1.07 NS
H11 . . A . T T . . G . . . 1.57 1.07 NS
H12 . A . . . . . . . . C . 1.91 0.67 NS
Global Test P50.0001
aIdentity with the most putatively ancestral (reference)haplotype H2 is indicated by a period. Indel marked by a dash. Predisposing mutations in
bold font. bOnly haplotypes with estimated frequencies 41% in the combined case and controls are included. Haplotypes numbered in order
of decreasing overall frequency.
Figure 4 MJ network of the 12 most common haplotypes in
the European case and control samples. Arrows link the unique
haplotypes and indicate the mutational relationships between
them. H5 includes H5 and H7. The size of a node is approxi-
mately proportional to the frequency of that haplotype in the
total sample (the most frequent haplotypes have been down-
scaled for clarity). Mutational steps are indicated on the branches
(variants numbered as in Table 2). The squared box indicates the
shared ‘ancestral’ European and Korean haplotype.
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R702W, G908R and 1007insC within a common back-
ground haplotype. Therefore it is not possible to discount
the argument that these three SNPs truly are the causative
variants. However, it still appears plausible that such a
variant may exist as yet undetected, perhaps in an upstream
promoter element. Indeed, in an exhaustive re-sequencing
of the CARD15 coding region of 457 CD patients, 159 UC
patients and 103 unaffected unrelated individuals, Hugot
et al27 found a large number of additional but extremely
rare missense variants that may also be associated to CD.
If an unique causative variant remains to be discovered
then the search may be targeted at individuals carrying
the common background haplotype for SNPs R702W,
G908R and 1007insC.
The fact that SNPs R702W, G908R and 1007insC are asso-
ciated with a common background haplotype has probably
been fortunate since the presence of several disease-predis-
posing alleles within a susceptibility locus, each in
association with a different background haplotype can
seriously compromise the ability to locate the susceptibility
locus by LD mapping.7,44 If the apparently causative SNPs
R702W, G908R and 1007insC had not shared a common
background haplotype then association may have been
much harder to detect. The mutant alleles of all three
mutations are rare (in the control sample 4.70, 0.60 and
5.00% respectively). If they had unconnected origins and
resided on unrelated haplotypes then they may have obfus-
cated each other in the single locus association tests.
Although haplotype analyses would have resolved this,
the likelihood of not observing the association to CARD15
in the first place would have been much greater.
The lack of disease-association of CARD15 in an Asian
population which experiences CD of equivalent phenotype
and incidence as the European population highlights the
importance of ethnic comparisons in identifying the
susceptibility genes for complex disorders. The combination
of examining ethnically shared variants and genealogical
reconstruction of haplotypes can be a powerful tool in
narrowing the search for causative mutations.
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